PRAX-114
PRAX-114-213
Phase 3 small_molecule completed
Quick answer
PRAX-114 for Major Depressive Disorder is a Phase 3 program (small_molecule) at PRECISION BIOSCIENCES INC with 1 ClinicalTrials.gov record(s).
Program details
- Company
- PRECISION BIOSCIENCES INC
- Indication
- Major Depressive Disorder
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- completed